United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$210Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
RA Capital Management
Wellington Management
Vertex Ventures
Janus Henderson Investors
Foresite Capital
Samsara BioCapital
Blue OwlSource recorded
Reported by FinSMEsSEC filing: $32M sold, first sale Nov 2017
From Obsidian Therapeutics's own website and the SEC filings it signed: 6 on the team.
On the board, as filediCarolyn NgJason GardnerKaren Hong
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Obsidian Therapeutics's investors include RA Capital Management, Wellington Management, Vertex Ventures, Janus Henderson Investors and Foresite Capital, and 8 more on record.
Obsidian Therapeutics has raised $210M across 2 rounds since 2017.
Obsidian Therapeutics's most recent round was a Series C of $161M in Apr 2024.
Its most recent round, $161M in Apr 2024, is also its largest on record.
Obsidian Therapeutics's first round on record, in Dec 2017, was backed by Alexandria Real Estate Equities, Amgen and Vertex and 3 others.
Obsidian Therapeutics's latest named round is a Series C, in Apr 2024.
Obsidian Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
